Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Proposed LCDs - Published for Review and Comments Sep 25, 2025
Open Public Meeting Announcement Multiple LCDs - October 30, 2025 Sep 25, 2025
Policy Revision(s) for Multiple Billing and Coding Articles - Effective September 25, 2025 Sep 25, 2025
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms (L39923) - R1 - Effective July 3, 2025 Sep 25, 2025
Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease (A59868) - R1 - Effective August 17, 2025 Sep 25, 2025
Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (A59872) - R1 - Effective August 17, 2025 Sep 25, 2025
Self-Administered Drugs - Process to Determine Which Drugs Are Not Usually Self-administered By the Patient (A53893) - R3 - Effective October 1, 2015 Sep 18, 2025
Local Coverage Determination (LCD) Finalized - Effective November 2, 2025 Sep 18, 2025
Micro Invasive Glaucoma Surgery L38299 - R6 - Effective November 17, 2024 Sep 18, 2025
Billing and Coding: Billing Limitations for Pharmacies (A56119) Retirement - Effective September 18, 2025 Sep 18, 2025
Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) Final LCD - Effective October 26, 2025 Sep 11, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R29 - Effective October 1, 2025 Sep 11, 2025
Policy Revision(s) for Local Coverage Determinations and Associated Billing and Coding Articles - Effective September 11, 2025 Sep 11, 2025
Billing and Coding: MolDX: Germline testing for use of PARP inhibitors (A55294) - R12 - Effective October 1, 2025 Sep 04, 2025
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58679) - R9 - Effective October 1, 2025 Sep 04, 2025
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R13 - Effective October 1, 2025 Sep 04, 2025
Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment (A57037) - R7 - Effective October 1, 2025 Aug 28, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R27 - Effective October 1, 2025 Aug 28, 2025
MolDX Open Public Meeting Announcement Multiple LCDs - October 8, 2025 Aug 28, 2025
Proposed LCDs - Published for Review and Comments Aug 28, 2025